Abstract
Inactivation of p53 by genetic or epigenetic means is a critical step in the pathogenesis of many cancers, including nonmelanoma skin cancers (NMSCs). Restoring the tumor-suppressor functions of mutant p53 is a theoretical approach to minimizing the progression of NMSC. Small-molecular-weight compounds capable of restoring wild-type p53 function therefore represent a novel approach to anti-oncogenesis. In a screen of more than 100,000 synthetic compounds, one agent — CP-31398 …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
